Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 46

1.

Monocytes but not lymphocytes carrying HIV-1 on their surface transmit infection to human tissue ex vivo.

Barreto-de-Souza V, Arakelyan A, Zicari S, Margolis L, Vanpouille C.

J Virol. 2016 Aug 24. pii: JVI.00742-16. [Epub ahead of print]

PMID:
27558419
2.

Standardization of a cytometric p24-capture bead-assay for the detection of main HIV-1 subtypes.

Merbah M, Onkar S, Grivel JC, Vanpouille C, Biancotto A, Bonar L, Sanders-Buell E, Kijak G, Michael N, Robb M, Kim JH, Tovanabutra S, Chenine AL.

J Virol Methods. 2016 Apr;230:45-52. doi: 10.1016/j.jviromet.2016.01.009. Epub 2016 Jan 22.

PMID:
26808359
3.

Distinct cytokine/chemokine network in semen and blood characterize different stages of HIV infection.

Vanpouille C, Introini A, Morris SR, Margolis L, Daar ES, Dube MP, Little SJ, Smith DM, Lisco A, Gianella S.

AIDS. 2016 Jan;30(2):193-201. doi: 10.1097/QAD.0000000000000964.

PMID:
26558730
4.

Genital Cytomegalovirus Replication Predicts Syphilis Acquisition among HIV-1 Infected Men Who Have Sex with Men.

Gianella S, Smith DM, Daar ES, Dube MP, Lisco A, Vanpouille C, Margolis L, Haubrich RH, Morris SR.

PLoS One. 2015 Jun 10;10(6):e0130410. doi: 10.1371/journal.pone.0130410. eCollection 2015.

5.

Valacyclovir Decreases Plasma HIV-1 RNA in HSV-2 Seronegative Individuals: A Randomized Placebo-Controlled Crossover Trial.

Vanpouille C, Lisco A, Grivel JC, Bassit LC, Kauffman RC, Sanchez J, Schinazi RF, Lederman MM, Rodriguez B, Margolis L.

Clin Infect Dis. 2015 Jun 1;60(11):1708-14. doi: 10.1093/cid/civ172. Epub 2015 Mar 3.

6.

A new antiviral: chimeric 3TC-AZT phosphonate efficiently inhibits HIV-1 in human tissues ex vivo.

Vanpouille C, Khandazhinskaya A, Karpenko I, Zicari S, Barreto-de-Souza V, Frolova S, Margolis L, Kochetkov S.

Antiviral Res. 2014 Sep;109:125-31. doi: 10.1016/j.antiviral.2014.06.019. Epub 2014 Jul 7.

7.

HIV-1 vaginal transmission: cell-free or cell-associated virus?

Barreto-de-Souza V, Arakelyan A, Margolis L, Vanpouille C.

Am J Reprod Immunol. 2014 Jun;71(6):589-99. doi: 10.1111/aji.12240. Epub 2014 Apr 15. Review.

8.

An ex vivo Model of HIV-1 Infection in Human Lymphoid Tissue and Cervico-vaginal Tissue.

Introini A, Vanpouille C, Grivel JC, Margolis L.

Bio Protoc. 2014;4(4). pii: e1047.

9.

Design, synthesis and biological evaluation of phosphorodiamidate prodrugs of antiviral and anticancer nucleosides.

McGuigan C, Bourdin C, Derudas M, Hamon N, Hinsinger K, Kandil S, Madela K, Meneghesso S, Pertusati F, Serpi M, Slusarczyk M, Chamberlain S, Kolykhalov A, Vernachio J, Vanpouille C, Introini A, Margolis L, Balzarini J.

Eur J Med Chem. 2013;70:326-40. doi: 10.1016/j.ejmech.2013.09.047. Epub 2013 Oct 9.

10.

Histocultures (tissue explants) in human retrovirology.

Arakelyan A, Fitzgerald W, Grivel JC, Vanpouille C, Margolis L.

Methods Mol Biol. 2014;1087:233-48. doi: 10.1007/978-1-62703-670-2_19.

11.

A multi-targeted drug candidate with dual anti-HIV and anti-HSV activity.

Balzarini J, Andrei G, Balestra E, Huskens D, Vanpouille C, Introini A, Zicari S, Liekens S, Snoeck R, HolĂ˝ A, Perno CF, Margolis L, Schols D.

PLoS Pathog. 2013;9(7):e1003456. doi: 10.1371/journal.ppat.1003456. Epub 2013 Jul 25.

12.

Interleukin-7 facilitates HIV-1 transmission to cervico-vaginal tissue ex vivo.

Introini A, Vanpouille C, Lisco A, Grivel JC, Margolis L.

PLoS Pathog. 2013 Feb;9(2):e1003148. doi: 10.1371/journal.ppat.1003148. Epub 2013 Feb 7.

13.

HIV-1 imposes rigidity on blood and semen cytokine networks.

Lisco A, Introini A, Munawwar A, Vanpouille C, Grivel JC, Blank P, Singh S, Margolis L.

Am J Reprod Immunol. 2012 Dec;68(6):515-21. doi: 10.1111/aji.12015. Epub 2012 Sep 24.

14.

Microbicides: still a long road to success.

Vanpouille C, Arakelyan A, Margolis L.

Trends Microbiol. 2012 Aug;20(8):369-75. doi: 10.1016/j.tim.2012.05.005. Epub 2012 Jun 15. Review.

15.

Exploiting the anti-HIV-1 activity of acyclovir: suppression of primary and drug-resistant HIV isolates and potentiation of the activity by ribavirin.

Vanpouille C, Lisco A, Introini A, Grivel JC, Munawwar A, Merbah M, Schinazi RF, Derudas M, McGuigan C, Balzarini J, Margolis L.

Antimicrob Agents Chemother. 2012 May;56(5):2604-11. doi: 10.1128/AAC.05986-11. Epub 2012 Feb 6.

16.

Semen of HIV-1-infected individuals: local shedding of herpesviruses and reprogrammed cytokine network.

Lisco A, Munawwar A, Introini A, Vanpouille C, Saba E, Feng X, Grivel JC, Singh S, Margolis L.

J Infect Dis. 2012 Jan 1;205(1):97-105. doi: 10.1093/infdis/jir700. Epub 2011 Nov 22.

17.

Topical tenofovir, a microbicide effective against HIV, inhibits herpes simplex virus-2 replication.

Andrei G, Lisco A, Vanpouille C, Introini A, Balestra E, van den Oord J, Cihlar T, Perno CF, Snoeck R, Margolis L, Balzarini J.

Cell Host Microbe. 2011 Oct 20;10(4):379-89. doi: 10.1016/j.chom.2011.08.015.

18.

Cervico-vaginal tissue ex vivo as a model to study early events in HIV-1 infection.

Merbah M, Introini A, Fitzgerald W, Grivel JC, Lisco A, Vanpouille C, Margolis L.

Am J Reprod Immunol. 2011 Mar;65(3):268-78. doi: 10.1111/j.1600-0897.2010.00967.x. Epub 2011 Jan 12.

19.

Contrasting roles for TLR ligands in HIV-1 pathogenesis.

Brichacek B, Vanpouille C, Kiselyeva Y, Biancotto A, Merbah M, Hirsch I, Lisco A, Grivel JC, Margolis L.

PLoS One. 2010 Sep 20;5(9). pii: e12831. doi: 10.1371/journal.pone.0012831.

20.

A new class of dual-targeted antivirals: monophosphorylated acyclovir prodrug derivatives suppress both human immunodeficiency virus type 1 and herpes simplex virus type 2.

Vanpouille C, Lisco A, Derudas M, Saba E, Grivel JC, Brichacek B, Scrimieri F, Schinazi R, Schols D, McGuigan C, Balzarini J, Margolis L.

J Infect Dis. 2010 Feb 15;201(4):635-43. doi: 10.1086/650343.

Items per page

Supplemental Content

Loading ...
Write to the Help Desk